Philadelphia, PA, United States of America

Tamaz Guliashvili

This inventor holds 11 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 2 EPO patents. Top assignees: Cytosorbents Corporation, University of Pennsylvania, General Electric Company. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tamaz Guliashvili. Retrieved from https://idiyas.com/inventor/tamaz-guliashvili

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 5)

% Patents Active = 90.9

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 15(Granted Patents)

Location History:

Philadelphia, PA (US) (2008 - 2023)
Monmouth Junction, NJ (US) (2021 - 2023)

Company Filing History:

8 out of 30

Cytosorbents Corporation

patents

2 out of 2,655

University of Pennsylvania

patents

1 out of 52,369

General Electric Company

patents

Years Active: 2008-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12208116 - Multi-functional hemocompatible porous bead sorbent for removing protein based toxins and potassium from biological fluids (2025-01-28),

2. 12121879 - Crosslinked polysaccharide based absorbents for removal of anti-A and/or anti-B antibodies from human plasma and whole blood (2024-10-22),

3. 11826724 - Use of a hemocompatible porous polymer bead sorbent for removal of endotoxemia-inducing molecules (2023-11-28),

4. 11723916 - Multi-functional hemocompatible porous polymer bead sorbent for removing protein based toxins and potassium from biological fluids (2023-08-15),

5. 11202855 - Methods for removal of toxins from blood using an extracorporeal circuit comprised of a hollow-fiber filter module and polymer sorbent in combination (2021-12-21),

6. 11065600 - Use of a hemocompatible porous polymer bead sorbent for removal of endotoxemia-inducing molecules (2021-07-20),

7. 11040061 - Multi-functional hemocompatible porous polymer bead sorbent for removing protein based toxins and potassium from biological fluids (2021-06-22),

8. 10889665 - Process for functionalizing a biocompatible polymeric bead, the functionalized beads, and the beads produced thereby (2021-01-12),

9. 8858803 - Methods of preparing novel halide anion free quaternary ammonium salt monomers, polymerization methods therefor, and methods of use of the resulting polymers (2014-10-14),

10. 7470762 - Living radical polymerization of acrylic monomers and the formation of block copolymers therefrom (2008-12-30),

11. 7345127 - Living radical polymerization of halogen-containing and acrylic monomers and the formation of block copolymers therefrom (2008-03-18),

Title: Innovations by Tamaz Guliashvili

Introduction

Tamaz Guliashvili is a prominent inventor based in Philadelphia, PA, known for his significant contributions to the field of biomedical engineering. With a total of 11 patents to his name, Guliashvili has developed innovative solutions aimed at improving health outcomes through advanced materials and technologies.

Latest Patents

One of his latest inventions is a multi-functional hemocompatible porous bead sorbent designed for removing protein-based toxins and potassium from biological fluids. This invention involves biocompatible polymer systems that include a polymer with numerous pores, featuring a sulfonic acid salt functionality. This design allows for the adsorption of a wide range of protein-based toxins, ranging from less than 0.5 kDa to 1,000 kDa, as well as positively charged ions such as potassium.

Another notable patent is focused on crosslinked polysaccharide-based absorbents for the removal of anti-A and/or anti-B antibodies from human plasma and whole blood. This invention utilizes polymeric media based on modified natural polysaccharides, which effectively remove Anti-A and Anti-B Antibodies from human blood or plasma. The media is designed to be stable under physiological pH conditions, ensuring its effectiveness in clinical applications.

Career Highlights

Throughout his career, Tamaz Guliashvili has worked with esteemed organizations such as Cytosorb

Profile summary based on public USPTO records.